SARS Test Available From CDC Within Weeks; Mutations May Hinder Diagnosis
This article was originally published in The Gray Sheet
Executive Summary
CDC remains cautious about the viability of a SARS diagnostic, citing the coronavirus' proclivity for mutations that may threaten performance of polymerase chain reaction (PCR) and antibody tests